98 related articles for article (PubMed ID: 2576357)
1. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep.
Abraham WM
Arzneimittelforschung; 1989 Oct; 39(10A):1328-31. PubMed ID: 2576357
[TBL] [Abstract][Full Text] [Related]
2. Antiallergic activity of picumast dihydrochloride in several animal species.
Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
[TBL] [Abstract][Full Text] [Related]
3. A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic sheep.
Abraham WM; Stevenson JS; Garrido R
J Pharmacol Exp Ther; 1988 Dec; 247(3):1004-11. PubMed ID: 3204511
[TBL] [Abstract][Full Text] [Related]
4. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
Zimmermann I; Roesch A; Ulmer WT
Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
[TBL] [Abstract][Full Text] [Related]
5. Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness.
Abraham WM; Lanes S; Stevenson JS; Yerger LD
Bull Eur Physiopathol Respir; 1986; 22(4):387-92. PubMed ID: 3768572
[TBL] [Abstract][Full Text] [Related]
6. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
Franke W; Bachert C; Messinger D
Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
Besenfelder E; Neubert P; Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis.
Boerner D; Metz K; Eberhardt R; Schürmann W
Arzneimittelforschung; 1989 Oct; 39(10A):1356-9. PubMed ID: 2576363
[TBL] [Abstract][Full Text] [Related]
9. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
Wilhelms OH; Roesch A; Schaumann W
Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
[TBL] [Abstract][Full Text] [Related]
10. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
Wittenbrink-Dix AM; Neugebauer G; Fuhr U; Neubert P; Besenfelder E; Woelke-Seidl E; Harder S; Staib AH
Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
[TBL] [Abstract][Full Text] [Related]
11. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
Franke W; Messinger D
Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
[TBL] [Abstract][Full Text] [Related]
12. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
Slapke J; Müller S; Boerner D
Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
Sekardi L; Friedberg KD
Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients.
Boerner D; Metz K; Eberhardt R
Arzneimittelforschung; 1989 Oct; 39(10A):1363-7. PubMed ID: 2576365
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
Neugebauer G; Wittenbrink-Dix AM; Woelke-Seidl E; Kaufmann B; Ponton T; Dahmen W; Mosberg H; Nieder N; Besenfelder E
Arzneimittelforschung; 1989 Oct; 39(10A):1336-9. PubMed ID: 2576358
[TBL] [Abstract][Full Text] [Related]
17. YM461, a PAF antagonist, blocks antigen-induced late airway responses and airway hyperresponsiveness in allergic sheep.
Tomioka K; Garrido R; Ahmed A; Stevenson JS; Abraham WM
Eur J Pharmacol; 1989 Nov; 170(3):209-15. PubMed ID: 2620695
[TBL] [Abstract][Full Text] [Related]
18. Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.
Abraham WM; Sielczak MW; Ahmed A; Cortes A; Lauredo IT; Kim J; Pepinsky B; Benjamin CD; Leone DR; Lobb RR
J Clin Invest; 1994 Feb; 93(2):776-87. PubMed ID: 8113411
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium antagonist gallopamil on antigen-induced early and late bronchoconstrictor responses in allergic sheep.
D'Brot J; Abraham WM; Ahmed T
Am Rev Respir Dis; 1989 Apr; 139(4):915-20. PubMed ID: 2930069
[TBL] [Abstract][Full Text] [Related]
20. Effects of an eosinophil chemotaxis inhibitor, TAK-661, on antigen-induced asthmatic responses in allergic sheep.
Fujimoto K; Tsunoda T; Koizumi T; Kubo K
Lung; 2002; 180(3):161-72. PubMed ID: 12177730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
